SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Sean McCarthy will participate on a panel at the Charlotte Biotechnology Conference titled "Financing Successful Biotech Companies", on the campus of UNC-Charlotte.
News | 10. 12. 2007
